Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM have agreed to collaborate on the development of a tool built upon IBM Watson that will help doctors create individualized cancer diagnostic and treatment recommendations for their patients based on current evidence.
The initiative will combine the computational power of IBM Watson and its natural language processing ability with MSKCC’s clinical knowledge, existing molecular and genomic data and repository of cancer case histories, in order to create an outcome and evidence-based decision support system. The goal is to give oncologists located anywhere the ability to obtain detailed diagnostic and treatment options based on updated research that will help them decide how best to care for an individual patient.
The IBM Watson system gained fame by beating human contestants on the television quiz show Jeopardy. It can interpret queries in natural language and uses statistical analysis, advanced analytics and an array of processors to search millions of pages in seconds and deliver evidence-based statistically-ranked responses.
[Image Courtesy: IBM]